Related Experiment Video

Updated: May 6, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

9.8K

Genomic Confirmation of HLA-B*47:14 by Next Generation Sequencing

Jarret Merschman1, Justin Kreuter1, Laurie Wakefield1

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

HLA
|May 5, 2026
PubMed
Abstract

None:

HLA-B*47:14 is characterised by a single nucleotide substitution in codon 97 of exon 3.

Keywords:
HLA‐B*47:14allele confirmationhistocompatibilityimmunogeneticsnext‐generation sequencing

More Related Videos

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.9K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

29.4K

Related Experiment Videos

Last Updated: May 6, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

9.8K
Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
07:17

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

1.9K
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

29.4K

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

12.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.7K
Next-generation Sequencing03:00

Next-generation Sequencing

88.0K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
88.0K

Articles linked to this work by shared authors, journal, and citation graph.

Characterisation of the Novel HLA-DQA1*01:205N Allele by Next Generation Sequencing and Oxford Nanopore Sequencing.

HLA·2026

Characterisation of the Novel HLA-DRB1*10:52 Allele by Next-Generation Sequencing and Oxford Nanopore Sequencing.

HLA·2026

Genomic Confirmation of HLA-DQA1*01:67:01 by Next Generation Sequencing and Oxford Nanopore Sequencing.

HLA·2026

Genomic Confirmation of HLA-DPA1*01:49 by Next Generation Sequencing and Oxford Nanopore Sequencing.

HLA·2026

Genomic Confirmation of HLA-B*15:591 by Next Generation Sequencing.

HLA·2026

Genomic Confirmation of HLA-C*01:155, by Next Generation Sequencing.

HLA·2026

Characterisation of a Novel HLA-DQA1 Allele by Next Generation Sequencing: HLA-DQA1*01:03:13.

HLA·2026

Identification of Two Novel HLA-A Alleles by Next-Generation Sequencing: HLA-A*01:516 and HLA-A*03:538.

HLA·2026

The Novel HLA-A*01:524 Allele With a Non-Synonymous Mutation in Exon 1 Identified in an Individual From North India.

HLA·2026

Characterisation of the Novel HLA-DRB1*14:02:13 Allele by Sequencing-Based Typing.

HLA·2026

Characterisation of the Novel HLA-C*06:390 Allele by Next-Generation Sequencing.

HLA·2026

The Novel HLA-B*51:397 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual.

HLA·2026

Highly Accurate Detection of Circulating Tumor DNA for Monitoring Minimal Residual Disease in Solid Tumors: Analytical and Clinical Validation of the Haystack MRD Assay.

The Journal of molecular diagnostics : JMD·2026

Protocol for untargeted multi-omics dried blood spot extraction using liquid chromatography-tandem mass spectrometry.

STAR protocols·2026

Protocol for detecting cancer in blood using targeted DNA methylation.

STAR protocols·2026

A protocol for untargeted metabolomics using anion-exchange chromatography and high-resolution mass spectrometry.

STAR protocols·2026

Response surface methodology-optimized microwell spectrophotometric method for saxagliptin quantitation: a sustainable, high-throughput approach for pharmaceutical quality control.

Analytical methods : advancing methods and applications·2026

Forensic integrity of blood alcohol sampling in the emergency department, Part II: Establishing quality goals of turnaround time with Monte Carlo simulation.

Biochemia medica·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us